The present review focuses on the current knowledge of the neurochemical processes and neuronal structures involved in the generation of P300. The increasing knowledge in this area facilitates the physiological interpretation of P300 findings as well as the link between P300 research and other research findings in biological psychiatry. Concerning the question of neurochemical substrates, the glutamatergic, GABAergic, cholinergic, noradrenergic, dopaminergic and serotonergic influences on P300 are reviewed. The knowledge of the generating structures of P300 is summarized from intracranial studies, magnetoencephalographic investigations, lesion and animal studies.
Introduction
Thirty-three years have passed since Sutton et al. [1] first described long-latency positive event-related potentials (ERPs). Now commonly referred to as the P300 (also called P3, P3b or LPC), this positive ERP occurs with a latency of about 300 ms after meaningful task-relevant target stimuli ( fig. 1 ). It is often elicited with a simple discrimination task, the 'oddball paradigm'. In this paradigm, two different stimuli are presented, with task-relevant target stimuli occurring less frequently than the nontarget or standard stimuli (e.g. with probabilities 0.20 and 0.80, respectively). The subject's task can be, for example, to press a button or to silently count the task-relevant stimuli which are presented in auditory, visual, somatosensory or olfactory modalities.
In the following years, P300 was studied extensively with different methods and paradigms. Most of these studies focused on the relationship between P300 and psychological principally cognitive aspects. Major theoretical interpretations of P300 amplitude are that it indexes the updating of the working memory [2] , or that it reflects context closure [3] . Considering experimental conditions, P300 amplitude is related to stimulus proba- Fig. 1 . The P300 can be typically elicited with a discrimination paradigm. A task-relevant target stimulus occurs less frequently than a nontarget stimulus (e.g. with probabilities 0.20 and 0.80, respectively). P300 is a positive ERP with a maximum at the parietocentral electrodes which occurs at about 300 ms after a task-relevant target stimulus when the subject has to perform a task, for example to press a button or to count the target stimuli (waveform at the bottom). After the occurrence of the nontarget stimulus no P300 is elicited (waveform at the top).
bility, stimulus significance, task difficulty, motivation and vigilance [4] . P300 latency is mainly influenced by the task complexity and is a reflection of stimulus evaluation and of response processing when response times are short under fast experimental conditions [reviewed in 5] .
Alterations of P300 have been found in various psychiatric disorders. In schizophrenia, P300 amplitude reduction is one of the most robust biological findings [6, 7] . Reduced P300 amplitudes were found to predict a bad clinical outcome with antipsychotic treatment [8] , incomplete remission [9] and a higher risk for tardive dyskinesia [10] . Furthermore, P300 latency was prolonged in some studies of schizophrenia [11] . In dementia, P300 amplitude reductions and latency prolongations have consistently been reported [12, 13] . These findings raised the question whether or not P300 could aid in the diagnosis of dementia [12, 14] . Moreover, P300 amplitudes were reduced in alcoholics and family members of alcoholics [15] . Furthermore, prolongations of P300 latency were reported in patients with HIV [16] and idiopathic parkinsonism [17] . In patients with depression, less consistent findings were made about P300 amplitude or latency.
The physiological interpretation of P300 data, however, has remained difficult, because among other problems, the question of its neural origin has not been solved. Knowledge of the neurochemical and neuroanatomical substrates of P300 would be important for the physiological interpretation of P300 findings and for relating P300 research to other research areas, such as neurochemical and neuroanatomical studies in psychiatry. The aim of this review is to summarize the present knowledge of the neurochemical processes and the neural structures involved in the generation of the auditory P300.
Neurochemical Substrates of the P300
The increasing knowledge of the anatomical structures and cellular processes underlying ERPs, and the methodological advances in analysis of ERPs offer a possibility to bridge the gap between ERPs and their basic neurophysiology. It is now widely accepted that ERPs result from intracortical currents induced by excitatory and inhibitory postsynaptic potentials (EPSPs, IPSPs), which are triggered by the release of neurotransmitters. Therefore, ERPs reflect postsynaptic effects of neurotransmitters like glutamate and GABA and indirect modulating effects from neuromodulators like acetylcholine, noradrenaline, dopamine or serotonine. They could become of clinical value as indicators for disturbances in these neurochemical systems. However, P300 can only be used as such an indicator when at least a certain specificity exists in the 88 Neuropsychobiology 1999; 40:86-94 Frodl-Bauch/Bottlender/Hegerl relationship between P300 and the different neurochemical systems. Therefore, it is necessary to characterize the role of neurotransmitters in the generation of P300.
Glutamatergic Influences
Physiological analysis and the application of the current source density method to intracortical recordings suggest that the EPSPs from the apical dendrites with sources in deeper layers near or at the soma are most likely to be responsible for slow cortical potentials [18] such as P300. The N-methyl-D-aspartate (NMDA) receptors, which are activated by glutamate could be of special importance. The glutamatergic system is the most important excitatory neurotransmitter system and plays an important role in the electrogenesis of P300 potentials [19] . As discussed, for example, by Javitt et al. [20] , these receptors have long EPSPs of 10-100 ms, which seem to correspond to late components such as P300. Furthermore, the effect of NMDA receptor activity on ERPs has been shown in animal experiments with intracranial recordings [20] . MK-801, a high-affinity high-specificity NMDA channel blocker, was administered intracortically in a monkey. The mismatch negativity (MMN), a late cognitive ERP, was reduced after the administration of MK-801. MMN precedes P300 and shares similarities with P300 because both P300 and MMN are events in the processing of stimulus deviance.
In addition, P300 and the NMDA receptor function have a remarkable similarity. Both P300 and NMDA receptor function depend on preconditions. The P300 component is elicited only after task-relevant stimuli. It is dependent on the precondition that a series of irrelevant standard stimuli has been presented when the deviating task-relevant stimuli occurs. On the other hand, potentials of NMDA receptors are blocked in a voltage-dependent fashion by Mg 2+ . The NMDA receptor function is dependent on the degree of membrane depolarization and, therefore, like P300, has a conditional aspect.
In summary, P300 is most likely caused by a direct excitatory postsynaptic effect of glutamatergic neurotransmission.
GABAergic Influences
GABA is the most important inhibitory neurotransmitter, and IPSPs triggered by GABAergic effects could also be responsible for late ERPs such as P300. The GABAergic transmission in the reticular nucleus of the thalamus has been suggested to contribute to positive cortical potentials via inhibitory hyperpolarization [21] . Then, indirect inhibitory influences on GABAergic IPSPs could reduce the negativity of some cortical brain regions and, therefore, could be measured as positive potentials. However, the findings from current source density methods point in another direction. It is more likely that slow cortical potentials are directly caused by EPSPs and not by IPSPs.
Another explanation of the GABAergic effects on P300 is that GABAergic influences decrease EPSPs [22] and, therefore, reduce P300. This is supported by findings which showed that sedating GABAergic drugs alter P300 parameters. P300 amplitudes were reduced [23, 24] and P300 latencies were delayed after the application of GABAergic drugs [25, 26] .
Taken together, the present results indicate that GABAergic influences on P300 generation are most likely to be indirect. These effects on P300 could result from inhibitory influences on glutamatergic EPSPs.
Cholinergic Influences
The cholinergic neurotransmitter system has indirectly modulating effects in widely distributed neuronal networks. Acetylcholine has been found to be involved in the generation of P300 [27] . Memory performance and P300 amplitude is increased after the administration of cholinergic substances and is reduced after the administration of anticholinergic substances [28] [29] [30] . Scopolamine, an anticholinergic substance, significantly reduces the P300 amplitude and increases its latency [31, 32] . The muscarinic agonist RS 86 increases P300 amplitudes in patients with Alzheimer's disease [33] .
Furthermore, animal studies investigating the influence of the septal cholinergic system on P300 [34, 35] found that septal cholinergic system lesions affect P300 in cats. The septal nuclei provide the major cholinergic input to the hippocampus (from the diagonal band of Broca and the medial septal nuclei) and to the neocortex (from the nucleus basalis of Meynert). However, it is not clear to what extend findings from animal studies can be generalized to explain neurochemical processes in humans.
In summary, the cholinergic system is an important neuromodulator of the P300-evoked potentials.
Noradrenergic Influences
Another important neuromodulator is noradrenaline. The results on the influences of noradrenergic substances on P300 are inconsistent. Findings on the influence of the substances clonidine, methylphenidate and D-amphetamine are difficult to interpret because these substances have not only adrenergic, but also dopaminergic, seroton-ergic or cholinergic activity. Clonidine, an alpha-2 adrenergic agonist, which reduces the firing rate of the locus ceruleus, slowed P300 latency and decreased P300 amplitude [36] [37] [38] . However, clonidine may produce anticholinergic effects which influence P300 per se [39] . Methylphenidate enhanced P300 amplitude in attention-deficit hyperactivity disorder children [40] . On the other hand, methylphenidate and D-amphetamine have also been found to not affect P300 [41, 42] . Therefore, further investigations are necessary to define the influences of adrenergic substances on P300 in humans.
In contrast to the inconsistencies concerning findings in humans, results from animal studies suggest that the noradrenergic system has a role in P300 generation. The noradrenergic locus ceruleus system has been implicated in information processing similar to that presumed to be indexed by P300-like potentials [43] . Lesions of the noradrenergic locus ceruleus caused reductions of P300 amplitude [44] . When clonidine was administered to 6 adult monkeys during an auditory 'oddball paradigm', a significant decrease in P300-like activity was observed [45] . Moreover, microinjections of alpha-2 antagonists and agonists in the temporoparietal junction resulted in significant reductions of P300 amplitudes in monkeys [46] . A model that could explain the inconsistent findings in humans and the adrenergic effects in animals proposes that noradrenaline has, at least to some extent, an inhibitory control on GABAergic activity. This indirect effect could contribute via inhibitory hyperpolarization to positive slow cortical potentials like P300 [21, 22] .
In summary, the adrenergic neuromodulator system seems to have minor influences on P300 elicited during P300 recordings in humans. Stronger noradrenergic effects on P300 have been demonstrated under experimental conditions in animal studies.
Dopaminergic Influences
Stanzione et al. [17] suggested that dopaminergic neurotransmission has a physiological role in the generation of P300. They studied P300 in idiopathic parkinsonian patients, in whom destruction of dopaminergic fibers was described, and found that P300 latency was increased before therapy. Therapy with L-DOPA plus benserazide reduced the prolonged latency. Taken together, the studies on patients with Parkinson's disease show prolonged P300 latencies for demented patients, whereas the results in nondemented patients concerning P300 latency and amplitude were inconsistent. Because of the influence of dementia in these studies, the disturbances in the dopaminergic system do not seem to be specific for these P300 findings. Another finding which speaks against an important role of the dopaminergic system in P300 generation is that dopaminergic fibers do not seem to be necessary for P300 because toxic lesions of these fibers do not affect the monkey P300 [47] .
In summary, the dopaminergic system seems to play a minor role in the generation of P300 processes.
Serotonergic Influences
Effects of the serotonergic agent fenfluramine and the antiserotonergic agent methysergide on P300 have not been reported until now. A prolongation of P300 latency only appears with combinations of antiserotonergic with anticholinergic substances [48] . These findings seem to focus on the interactive role between serotonergic and cholinergic substances in EEG modulation [49] .
Further investigations will be needed to evaluate the neurobiological effect of serotonergic activity on P300. To date, the serotonergic system does not seem to have a modulatory role in P300 generation.
Summary of Findings on the Neurochemical Substrates of P300
Various neurochemical influences were found on P300 generation. A model of neurochemical influences on P300 is presented in figure 2 . P300 generation is triggered by the neurotransmitter glutamate, which is the most important excitatory neurotransmitter. An important modulator of these EPSPs caused by glutamate and, therefore, of this P300 activity is the cholinergic neurotransmission, which increases P300 amplitude and decreases P300 latency. On the other hand, GABAergic influences on EPSPs reduce P300 amplitude and prolong P300 latency.
Other neuromodulator systems seem to be less important for P300 generation. They seem to have, at least to some extent, indirect influence on other neurochemical systems like the GABAergic and cholinergic system, which are important for P300 generation. Modulation of any one neurochemical system will necessarily modulate many other neurochemical systems.
This complex pattern of neurotransmitter influences can explain why P300 is altered in several psychiatric disorders. Considering the glutamate hypothesis in schizophrenia, the reduced amplitude of P300 in schizophrenics could stem from disturbances in the glutamatergic system. Reduced amplitudes and prolonged latencies of P300 in dementia could be due to alterations in the cholinergic system.
Frodl-Bauch/Bottlender/Hegerl Findings about neurochemical substrates of the P300 suggest this hypothetical model of P300 generation. The glutamatergic neurotransmission directly causes the EPSPs, which are responsible for the P300 activity. These EPSPs and as a consequence the P300 are modulated both indirectly by influences of acetylcholine, enhancing P300 amplitude and decreasing P300 latency, and by influences of GABA, reducing P300 amplitude and prolonging P300 latency. The adrenergic system and with minor importance, the dopaminergic and serotonergic systems seem to have indirect influence on the indirect effects of the acetylcholinergic and GABAergic systems and, thus, have shown inconsistent findings concerning P300 in humans.
Generators of P300
In this section we will review the macroanatomical P300 generators. The distribution of the electric fields throughout the brain and at the surface of the scalp is determined by the spatial distribution of the neurons as well as by the geometry and impedance of the brain and its coverings [50] . The presupposition for summing up microfield activities and for producing a so-called 'far or open field', which is volume conducted to the surface, is that the neurons have a laminar and columnal organization. This is the case for cortical neurons. Otherwise, when microfields cancel each other, they are named 'closed fields'. Neuronal activity within closed fields will not be recorded in the scalp data. P300 seems to be more complex than previously thought. Indeed, P300 is a composite of the activity arising from different brain generators [51] . Invasive methods, like intracranial recordings, lesion studies, lobectomy investigations and animal studies can provide evidence for the localization of P300 generators.
A number of studies analyzing P300 with intracranial electrodes have suggested the importance of the medial temporal lobe structures for P300 generation. Halgren et al. [52] recorded large P300 potentials from electrodes implanted in the hippocampus, parahippocampal gyrus and amygdala of epileptic patients. Okada et al. [53] and Wood et al. [54] found comparable results from studies using simultaneous scalp recordings. These results indicated a local origin of the P300 in the limbic system. Studies demonstrating the broad P300 scalp distribution were consistent with a deep generator [55, 56] .
However, the newest evidence shows that the limbic system probably has only a small influence on the generation of the scalp-recorded P300 because of several reasons:
(1) The hippocampus does not seem to produce a far field large enough to be measured at the scalp electrodes because of its special anatomy and its location deep in the temporal lobe. Deep structures, such as the hippocampus, are unlikey to be direct generators of the large 10-20 ÌV P300-potentials recorded on the scalp [57] .
(2) The studies of Paller et al. [58] presented evidence against the hippocampal generation of P300. The P300 wave was still present in monkeys with bilateral excisions to the medial temporal lobe. Arguments against these studies were that the excisions may not have affected all P300-generating structures in the temporal lobe or that other structures compensated for the disturbances.
(3) Investigations in epileptic patients after temporal lobectomies did not show any significant difference from normal subjects as to P300 [59] [60] [61] [62] . However, the posterior hippocampus, which can produce large P300-like amplitudes [63] , typically is spared in lobectomies. Thus, this argument does not exclude a far-field P300 generator in the posterior hippocampus.
(4) A patient with extensive damage to the left medial temporal lobe caused by an infiltrating glioma did not have changed P300 parameters [64] .
(5) Recent investigations with intracranial electrode recordings have provided the best knowledge of P300 generators [65, 66] . It was concluded that the strong voltage gradients of hippocampal activity make a direct participation of this structure in the production of P300 scalp potentials unlikely.
P300 activity was observed with intracranial electrodes in multiple sites of the temporal and parietal cortices. These structures were the posterior and superior parietal cortices [65, 66] , the parietooccipital cortex [67] , the inferior parietal lobule [68] , the marginal gyrus [69] , the sulcus temporalis superior [65, 66] and the posterior cingulate gyrus [66] . These findings are supported by lesion studies. Yamaguchi and Knight [70] found reduced P300 in patients with temporoparietal lesions, and Verleger [71] replicated this finding. Yamaguchi and Knight [70] also reported that unilateral damage to the temporoparietal cortex decreases P300 over both hemispheres. Therefore, the integrity of the temporoparietal junction seems to be necessary for P300 generation.
Furthermore, correlations of magnetic resonance imaging with P300 amplitudes [72] raise the possibility that the temporoparietal cortices are important areas for modulating and triggering P300. Direct evidence for a relationship between cortical abnormalities and reduced P300 comes from McCarley et al. [73] . This research group found that temporal lobe tissue loss in schizophrenics correlated significantly with changes in P300.
Moreover, animal studies reporting local microinjections of noradrenaline agonists and antagonists [46] in the temporoparietal cortices of monkeys and observations of single-unit activity in these cortices during discrimination tasks in monkeys have indicated that these cortices are generators of late positive P300 activity [74, 75] .
In summary, P300 seems to be generated directly in widespread cortical areas of the temporoparietal junction and in the parietal cortices. Nevertheless, some indirect influences of subcortical structures, like the limbic system, have to be considered in explanations of P300 generation. These conclusions are in line with the reduced P300 amplitudes in patients with dementia of the Alzheimer type, who show volume loss in the temporoparietal cortical areas.
P300 Subcomponents
Findings from intracranial recordings, scalp data analysis and dipole source analysis suggest that various P300 subcomponents overlap at the surface scalp electrodes and produce P300 with a maximum at the parietocentral electrodes. The consequence is that functionally different physiological processes overlap and are difficult to investigate. A methodological advance is the dipole source model of P300, which is able to separate two P300 subcomponents directly from the surface scalp data [76] . These are a temporoparietal subcomponent, which seems to correspond to the parietally recorded P300, and a temporofrontal P300 subcomponent, which might correspond to the frontally recorded P300.
Moreover, with intracranial recordings, multiple generators were suggested for the various P300 subcomponents. Nevertheless, it remains unclear which of these structures are far-field generators and are volume conducted to the surface, and which are so-called closed-field generators whose effects are locally restricted.
With intracranial recordings, three different waveforms can be observed in several brain sites [65, 66] . These waveforms are modality-specific auditory P300, N2/P3a/SW components and P3b components, reflecting different physiological processes [77, 78] . P3b, which is generally regarded as the main component of P300, has a maximum at parietocentral electrode sites, whereas P3a is located over the frontal cortex and appears especially after nontarget or novel stimuli. The slow wave has been described as 'negative-going' over frontal areas and 'positive-going' over parietal areas [77, 79, 80] .
P3b is the most prominent P300 subcomponent. Additionally, a modality-specific auditory P300 generator has recently been found with intracranial recordings in the dorsal superior temporal plane, especially when the nontargets were subtracted from the targets [65, 66] . With magnetoencephalographic recordings, the temporal plane has been shown to play an important role in P300 generation [81] . Moreover, N2/P3a/SW components have been observed in several diffusely distributed brain structures. These triphasic waveforms have been found in the orbitofrontal cortex, the anterior and posterior cingulate cortices, the supramarginal gyrus and in some sites of the temporal cortices [65, 66, 68, [82] [83] [84] . The prefrontal cortex, which is thought to carry out some major integrative functions, involving sensory as well as motoric and autonomic processes [85] , might play a role in the generation of this P3a because P3a was significantly diminished in both hemispheres after unilateral damage to the prefrontal cortex [86] .
Summary of the Findings on P300 Generators
The P300 generators are localized in multiple cortical areas. P300, also named P3b, seems to be generated in the Frodl-Bauch/Bottlender/Hegerl parietal cortical areas and the temporoparietal cortices. This component is most prominent in scalp data analysis with a maximum over the parietocentral electrodes.
Moreover, to what extent other distinct waveforms can be measured by the surface electrodes is unclear. N2/P3a/ SW waveforms seem to be elicited in multiple sites of the frontal, temporal and parietal cortices. In auditory paradigms, a modality-specific P3aud. seems to originate from the superior temporal plane.
Conclusion
With respect to the neurochemical substrates and neuroanatomical generators of P300, there appears to be a direct triggering by glutamatergic neurotransmission in the temporoparietal junction, the parietal cortical areas and, less evident, in the medial temporal lobe structures. However, the activity of the medial temporal lobe structures does not seem to be volume conducted to the surface and to have only little influence on the generation of the scalp-recorded P300. This P300 activity is modulated indirectly by cholinergic influences, enhancing P300 amplitudes and decreasing P300 latencies, and by GABAergic influences, reducing P300 amplitudes and prolonging P300 latencies. The adrenergic, dopaminergic and serotonergic systems seem to be less important and to have more indirect influence on other neurochemical systems affecting P300, such as those of GABA and acetylcholine.
Recently, intracranial recordings and subcomponent analysis have shown that P300 is composed of subcomponents (P3b, P3a, SW, modality-specific auditory P300) which have different scalp distributions, different underlying neural generators and are modulated by different neurochemical processes. In addition to this P3b component, a modality-dependent auditory P300 generator has been observed on the temporal plane of the gyrus temporalis superior and diffuse P3a/SW generators have been found in multiple areas of the frontal, temporal and parietal cortices. However, it remains unclear which of these generators contribute to the surface P3a. Further studies are necessary to identify these underlying generators and, in particular, their neurochemical substrates.
